US-German biotech Galimedix Therapeutics has unveiled preclinical data for a next-generation oral Alzheimer’s candidate, pointing to improved pharmacokinetics that could support lower dosing and more ...
Indian drugmaker Glenmark Pharmaceuticals has announced the introduction of two generic products to the US market.
Danish pharma major Novo Nordisk late Thursday announced that the US Food and Drug Administration (FDA) has approved Wegovy HD (once-weekly injectable semaglutide 7.2mg) to reduce excess body weight ...
British pharma major AstraZeneca (LSE: AZN) is stepping up its China strategy with plans to build a commercial cell therapy manufacturing and supply base in Shanghai, alongside a new innovation center ...
US drugmaker Collegium Pharmaceutical has agreed to buy Corium Therapeutics' attention deficit hyperactivity disorder (ADHD) drug Azstarys (serdexmethylphenidate and dexmethylphenidate) for $650 ...
Latin America has never been short of markets that look promising on paper and frustrating in practice. Brazil still belongs ...
US pharma giant Pfizer (NYSE: PFE) has announced positive topline results from the Phase III TALAPRO-3 study. All the news ...
Adding to the growing list of newcomers to the fast-growing obesity and metabolic disease space, privately-held Endevica Bio ...
UK pharma major GSK (LSE: GSK) has announced that the US Food and Drug Administration (FDA) has approved Lynavoy (linerixibat) for the treatment of cholestatic pruritus in adult patients with PBC. All ...
A UK-based biotechnology company developing next-generation targeted protein degradation (TPD) therapies. Amphista Therapeutics focuses on rationally designed “targeted glue” molecules that harness ...
US rare disease drug developer Sarepta Therapeutics today provided an update on its ongoing regulatory interactions with the US Food and Drug Administration (FDA) regarding Amondys 45 (casimersen) and ...
In a field as crowded as weight loss, a company that can boast an entirely new approach is a rare find, but Atrogi appears to offer just that.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results